Swissmedic announced its approval on Wednesday making Nuvaxovid the first protein-based vaccine to be licensed in Switzerland. The American biotech firm Novavax had applied for approval on February 14 through Swiss partner Future Health Pharma.
Unlike other Covid-19 vaccine approved in Switzerland – the mRNA vaccines from Pfizer/BioNTech and Moderna and the viral vector vaccine from Johnson & Johnson – Nuvaxovid is a protein-based vaccine. According to Swissmedic, it contains a non-infectious component from the surface of the SaRS-CoV-2 virus which triggers a protective immune response when the body’s immune cells come into contact with it. The vaccine contains an adjuvant to strengthen the immune response.
The vaccine must be administered in two doses three weeks apart. The level of protection offered by Nuvaxovid seven days after the second dose is 90%. It can be stored in a refrigerator for up to nine months.
“We are proud that Switzerland is part of the growing list of countries approving Nuvaxovid and that people in Switzerland will have a protein-based Covid-19 vaccine option,” said Novavax CEO Stanley C. Erck.
Swissmedic’s decision was based on the totality of preclinical, manufacturing and clinical trial data submitted for review. This includes two pivotal phase III clinical trials: PREVENT-19, which enrolled approximately 30,000 participants aged 18 and older in the US and Mexico and was published in the New England Journal of Medicine.
Swiss forests better equipped for storms 25 years after Lothar
This content was published on
Twenty-five years after Hurricane Lothar wreaked havoc in Switzerland, the country’s forests are better prepared, experts say.
Media: Swiss medical services done abroad are billed at Swiss rates
This content was published on
In Switzerland, some medical services carried out abroad are still billed at Swiss rates, despite costing less, RTS reports.
This content was published on
Sophie Hediger, a member of the Swiss national snowboard cross team, has died in an avalanche in Arosa. She was 26 years old.
This content was published on
Several Swiss films exceeded the 100,000 admissions mark worldwide in 2024 and received widespread praise at international film festivals.
Swiss Alpine resorts covered in white gold for Christmas
This content was published on
Many areas at low altitudes in Switzerland are enjoying a blanket of snow. In the mountains, intense precipitation has delighted skiers.
SWISS makes emergency landing in Austria after smoke in cockpit
This content was published on
Swiss International Airlines (SWISS) made an emergency landing of an Airbus in Graz, Austria on Monday evening after engine problems.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.